Hostname: page-component-77c89778f8-swr86 Total loading time: 0 Render date: 2024-07-18T20:00:39.715Z Has data issue: false hasContentIssue false

Chaos Unleashed: The impact of recreational drugs and COVID on young adults

Published online by Cambridge University Press:  01 September 2022

A. Makela*
Affiliation:
Cambridge Health Alliance/Harvard Medical School, Department Of Psychiatry, Cambridge, United States of America Harvard Medical School at Cambridge Health Alliance, Department Of Psychiatry, Cambridge, United States of America
M. Howard
Affiliation:
Cambridge Health Alliance/Harvard Medical School, Department Of Psychiatry, Cambridge, United States of America Harvard Medical School at Cambridge Health Alliance, Department Of Psychiatry, Cambridge, United States of America
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

This case series reveals a number of young adults, whom after chronic use of recreational drugs, suffer the life-long consequence of severe chronic mental illness.

Objectives

• Review the illicit drugs that are commonly associated with psychotic symptoms. • Highlight exposures theorized to impact genetics associated with DSM 5 diseases. • Compare trends in illicit drug use during the worldwide COVID pandemic.

Methods

A literature review is used to examine the impact of COVID pandemic on illicit drug use in metropolitan cities in European countries and compare the trends with what is seen by the consult liaison psychiatry service at a metropolitan community hospital in the USA.

Results

In European Countries with data available, there were measurable differences in which illicit drugs were used most during the COVID 19 pandemic. In the US this data is not readily available at the time of submission for proper comparisson.

Conclusions

Although definitive comparrison is pending, the results of extensive illicit drug use demostrate a high comorbidity with psychotic spectrum disorders in the DSM 5.

Disclosure

No significant relationships.

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.